Evidence map›Paper›PMID 31822959›Full record

GuidelineEuropean journal of nuclear medicine and molecular imaging2020

[

Cristina Nanni, Lucia Zanoni, Tore Bach-Gansmo, Heikki Minn, Frode Willoch, Trond Velde Bogsrud, Ephraim Parent Edward, Bital Savir-Baruch, Eugene Teoh, Fenton Ingram and 2 more

Abstract readPractice Guideline
PubMed Publisher
In one paragraph

Guideline in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. [European journal of nuclear medicine and molecular imaging · 2026
    Trial
  2. [Tomography (Ann Arbor, Mich.) · 2022
    Trial
  3. [European journal of nuclear medicine and molecular imaging · 2021
    Trial
  4. Physiological biodistribution ofFrontiers in nuclear medicine · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Comparison of [Molecular imaging and biology · 2022
    Article
  9. Review
  10. Article
  11. Review
  12. Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  13. [Cancers · 2022
    Article
  14. Positivity Rate of [Molecular imaging and biology · 2022
    Article
  15. Article
  16. Importance of tumor subtypes in cancer imaging.European journal of radiology open · 2022
    Review
  17. Utility ofAJR. American journal of roentgenology · 2021
    Article
  18. The Clinical Utility ofMolecular imaging and biology · 2021
    Article
  19. The Role of [Cancers · 2021
    Article
  20. Diagnostic performance ofAmerican journal of nuclear medicine and molecular imaging · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cristina NanniMNM AOU S.Orsola-Malpighi, Bologna, Italy. cristina.nanni@aosp.bo.it.ORCID 0000-0003-2000-1599
Lucia ZanoniMNM AOU S.Orsola-Malpighi, Bologna, Italy.
Tore Bach-GansmoDepartment of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Heikki MinnDepartment of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland.
Frode WillochDepartment of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Trond Velde BogsrudPET-Centre, University Hospital of North Norway, Tromso, Norway.
Ephraim Parent EdwardDepartment of Radiology and Imaging Services, Emory University, Atlanta, GA, USA.
Bital Savir-BaruchDivision of Nuclear Medicine, Department of Radiology, Loyola University Medical Center, Maywood, IL, USA.
Eugene TeohDepartment of Oncology, University of Oxford, Oxford, UK.
Fenton IngramDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.
Stefano FantiMNM AOU S.Orsola-Malpighi, Bologna, Italy.
David M SchusterDivision of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this guideline is to provide standards for the recommendation, performance, interpretation, and reporting of [

Indexed as

CyclobutanesProstatic NeoplasmsHumansMalePositron Emission Tomography Computed TomographyCyclobutanes[18F]FluciclovineGuidelinePETProstate cancerRestagingStaging

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.